TargetTyrosine-protein kinase TXK(Homo sapiens (Human))
Dongguan Zhenxing-Beite Medicine Technology
US Patent
Dongguan Zhenxing-Beite Medicine Technology
US Patent
Affinity DataIC50: 4.54E+3nMAssay Description:The inhibitory activities of the compound to Tec, Txk, and ITK of human were performed by Eurofins Pharma Discovery Services UK Limited (UK) of the U...More data for this Ligand-Target Pair